Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways
about
Sodium butyrate induces growth inhibition and apoptosis in human prostate cancer DU145 cells by up-regulation of the expression of annexin A1Mass spectrometric identification of ancient proteins as potential molecular biomarkers for a 2000-year-old osteogenic sarcomaThree measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment.WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice.Kinesin family member 4A: a potential predictor for progression of human oral cancerANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.Adenosine A2b receptor promotes progression of human oral cancerSemaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell CarcinomaAnnexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathwayARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.TGF-β/MAPK signaling mediates the effects of bone marrow mesenchymal stem cells on urinary control and interstitial cystitis after urinary bladder transplantation.Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.Mitogen-activated protein kinase signaling pathway in oral cancer.Annexin A10 contributes to chronic constrictive injury-induced pain through activating ERK1/2 signalling in rats.Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp.Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels.Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.Annexin A10 is a marker for the serrated pathway of colorectal carcinoma.
P2860
Q28533755-19CEF5A4-A285-4856-BBB1-19D43D32B4A5Q28539210-FE328893-4CC3-4FCC-BEB2-3BA4CB06AC72Q33648565-D4EED887-20C9-42F0-8407-B26238D26B25Q35003999-3F26001B-A926-4233-95D5-4C1F19B141DBQ35081235-395E96AA-A86E-4599-9C94-C87093E1D395Q35602157-F8351548-A70D-4D92-8A44-3338CD8ADD0DQ35728866-634DED48-A321-4AB8-8F33-7EB2853467CFQ35778398-E4323E7E-BB27-4080-904D-2C4DCB3CC328Q35836951-33C79991-E29C-4759-8690-18D0A8912ACFQ36037920-25F2730F-A589-4DC3-AA43-6401296DF01EQ36792366-6D2F53BC-AEAB-417A-84AE-F0CEE3258922Q37587416-71270C53-E8F4-49F1-BE8F-5B4FBC0BBAD4Q37661304-4F4EC408-D859-45F4-9F1B-EFFD8CF6FB75Q37733006-85EA6A1F-9D38-4FEE-A482-2B7C55694717Q44536954-B9E202AC-D981-418A-A9C5-18AE0D041A91Q47124790-D5AE5D51-8EDB-45BA-B819-FA548633A840Q47426573-67E66064-AAA0-4D34-94B4-84FE85D5DCC3Q49438304-08A9CFAB-7E46-4609-9F66-DABD3A62E75BQ50229789-1C744C22-7BE9-4135-BEFB-75800BFF7CF1Q51063025-4AC913FF-05C9-4482-9F0A-DE27822C5AA3Q51081188-A318A91C-D05B-43E7-9672-B9D023E1EF38Q51135450-55F3BF43-8255-4A8C-A8D3-B270927030EAQ54196328-BA61BD43-61BD-4C03-8F08-86D6E0BCB527Q54309791-D4B33057-C164-4DD2-867C-40D3C2C21C66
P2860
Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@ast
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@en
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@nl
type
label
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@ast
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@en
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@nl
prefLabel
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@ast
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@en
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@nl
P2093
P2860
P1433
P1476
Annexin A10 in human oral canc ...... geting MAPK signaling pathways
@en
P2093
Atsushi Kasamatsu
Ayumi Yamamoto
Hideki Tanzawa
Hiroaki Takatori
Katsuhiro Uzawa
Katsunori Ogawara
Kazuyuki Koike
Masashi Shiiba
Shunsaku Ishige
Toshihiro Shimizu
P2860
P304
P356
10.1371/JOURNAL.PONE.0045510
P407
P577
2012-09-17T00:00:00Z